Radient Pharmaceuticals Corporation fka RXPC

[dcspka]

Like you say, the lab equipment is small potatoes.

The required money for Provista to go forward with bringing its products to market is not in doubt- even Living agrees that Provista is doing well.

The fact that Provista is going to use DR-70 for both its Breast and Lung Cancer tests has been proven many times- Living needs to read the myriad of articles on the subject which have been posted on this MB. Statements from our Friendly Skeptics that Provista is going to steal DR-70 away have also been proven to be false.

The only point of contention is what will Gartner/Mac/Radient get in return for all of the work they have done leading up to this point? Will there be a reverse merger or not? Will the shareholders see Radient re-apply as a corporation and with the SEC? On and On it goes.

I say yes, they say no.
I say we will get a lot more than .0001 per share, they say no.

When will it all stop- as soon as Provista gets solid results on its Breast Cancer testing.